首页> 外国专利> METHODS AND COMPOSITIONS FOR IMMUNOTHERAPY AND DETECTION OF INFLAMMATORY AND IMMUNE-DYSREGULATORY DISEASE, INFECTIOUS DISEASE, PATHOLOGIC ANGIOGENESIS AND CANCER

METHODS AND COMPOSITIONS FOR IMMUNOTHERAPY AND DETECTION OF INFLAMMATORY AND IMMUNE-DYSREGULATORY DISEASE, INFECTIOUS DISEASE, PATHOLOGIC ANGIOGENESIS AND CANCER

机译:免疫治疗和检测炎症和免疫失调性疾病,感染性疾病,病原性血管生成和癌症的方法和成分

摘要

Methods and compositions for immunotherapy of inflammatory and immune-dysregulatory diseases, using multispecific antagonists that target at leasttwo differentmarkers are disclosed. When the multispecific antagonist reacts specificallywith a targetassociated with an inflammatory or immune-dysregulatory disorder, with apathologicangiogenesis or cancer, or with an infectious disease, it also bindsspecifically with at leastone proinflammatory effector of the immune system or at least one coagulationfactor. Thus,the multispecific antagonist contains at least one binding specificity relatedto the diseasedcell or condition being treated and at least one specificity to a component ofthe immunesystem. The multispecific antagonists are used in the treatment of variousdiseases that aregenerated or exacerbated by, or otherwise involve, proinflammatory effectorsof the innateimmune system or coagulation factors.
机译:炎性和免疫性免疫疗法的方法和组合物使用至少靶向至少一种多特异性拮抗剂的失调性疾病两种不同标记被公开。当多特异性拮抗剂特异性反应时有目标与炎症或免疫调节异常有关病理的血管生成或癌症,或具有传染性疾病,它也会结合特别是至少免疫系统的一种促炎效应子或至少一种凝血因子。从而,多特异性拮抗剂包含至少一种与结合特异性相关的患病被治疗的细胞或病症,以及对一种成分的至少一种特异性免疫系统。多特异性拮抗剂用于治疗各种哪些疾病由促炎性效应子产生或加剧,或以其他方式涉及促炎性效应子天生的免疫系统或凝血因子。

著录项

  • 公开/公告号CA2587143C

    专利类型

  • 公开/公告日2017-12-05

    原文格式PDF

  • 申请/专利权人 IMMUNOMEDICS INC.;

    申请/专利号CA20052587143

  • 发明设计人 GOLDENBERG DAVID M.;HANSEN HANS J.;

    申请日2005-12-08

  • 分类号C07K16;A61K39;A61K39/395;A61M36/14;C12P21/08;C07K1;

  • 国家 CA

  • 入库时间 2022-08-21 12:48:20

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号